CSIMarket
 
Healthcare Sector

Biotechnology & Pharmaceuticals Industry  




Data by Company within Biotechnology & Pharmaceuticals Industry


  Marketcap Revenues (TTM) Net Income (TTM) Employees
Company (Millions) (Millions) (Millions) Number
Amgen Inc $ 149,769 $ 28,190 $ 6,717 24,200
Gilead Sciences Inc $ 91,924 $ 27,116 $ 5,613 14,400
Seagen Inc $ 43,034 $ 2,300 $ -750 2,700
Moderna Inc $ 36,779 $ 6,848 $ -4,714 2,700
Biogen Inc $ 32,624 $ 9,836 $ 1,162 9,610
Argenx se $ 22,362 $ 856 $ -710 -
Neurocrine Biosciences Inc $ 13,752 $ 1,887 $ 250 1,000
Bio techne Corp $ 11,718 $ 1,143 $ 224 3,000
Repligen Corp $ 10,944 $ 670 $ 116 1,170
Vaxcyte Inc $ 8,240 - $ -300 -
Crispr Therapeutics Ag $ 7,077 $ 170 $ -354 -
Exelixis Inc $ 6,939 $ 1,830 $ 465 566
Immunovant Inc $ 5,544 - $ -243 -
Abcam Plc $ 5,511 - $ 0 -
Halozyme Therapeutics Inc $ 5,342 $ 829 $ 282 3,011
Krystal Biotech Inc $ 4,769 - $ 11 -
Iovance Biotherapeutics inc $ 4,294 - $ -433 -
Orchard Therapeutics Plc $ 3,814 $ 22 $ -73 -
Beam Therapeutics Inc $ 3,562 $ 82 $ -314 -
Revolution Medicines Inc $ 3,345 $ 30 $ -331 -
Recursion Pharmaceuticals Inc $ 3,326 $ 47 $ -293 -
Springworks Therapeutics Inc $ 3,287 - $ -348 -
Arcellx Inc $ 3,275 - $ -130 -
Denali Therapeutics Inc $ 3,214 $ 341 $ 330 340
Ginkgo Bioworks Holdings Inc $ 2,985 $ 315 $ -855 -
Twist Bioscience Corporation $ 2,357 $ 262 $ -206 750
Adaptimmune Therapeutics Plc $ 2,322 $ 76 $ -95 -
Jasper Therapeutics Inc $ 2,307 - $ -61 -
Immunitybio inc $ 2,288 $ 1 $ -459 -
Vericel Corporation $ 2,287 $ 185 $ -10 -
Kymera Therapeutics Inc $ 2,250 $ 67 $ -103 -
Sana Biotechnology Inc $ 1,993 - $ -280 -
Inhibrx Inc $ 1,865 $ 0 $ -189 -
Precision Biosciences Inc $ 1,847 $ 52 $ -74 -
Ambrx Biopharma Inc $ 1,737 $ 9 $ -134 -
Opthea Limited $ 1,562 $ 0 $ -143 -
Instil Bio Inc $ 1,532 $ 1 $ -197 -
Vir Biotechnology Inc $ 1,532 $ 86 $ -615 -
Mesoblast Ltd $ 1,530 $ 8 $ -82 -
Apogee Therapeutics inc $ 1,435 - $ 0 -
Scholar Rock Holding Corp $ 1,377 $ 47 $ -159 -
Adma Biologics Inc $ 1,290 $ 233 $ -23 256
4d Molecular Therapeutics Inc $ 1,264 $ 22 $ -96 -
Relay Therapeutics Inc $ 1,258 $ 26 $ -327 -
Tarsus Pharmaceuticals Inc $ 1,201 $ 17 $ -108 -
Biocryst Pharmaceuticals Inc $ 1,113 $ 318 $ -236 192
Cabaletta Bio Inc $ 1,081 - $ -62 -
Autolus Therapeutics Plc $ 1,068 $ 0 $ -149 -
Curis Inc $ 968 $ 10 $ -47 -
Regenxbio Inc $ 878 $ 99 $ -261 300
Neumora Therapeutics Inc $ 867 - $ 0 -
Fusion Pharmaceuticals Inc $ 863 $ 2 $ 84 -
Prime Medicine Inc $ 862 - $ -13 -
Allogene Therapeutics Inc $ 862 $ 0 $ -333 -
Valneva Se $ 836 $ 390 $ -82 550
Cullinan Oncology Inc $ 768 - $ -157 2
Icosavax Inc $ 766 $ 1 $ -97 -
Vectivbio Holding Ag $ 745 $ 27 $ -94 -
Fate Therapeutics Inc $ 735 $ 106 $ -173 208
Aerie Pharmaceuticals Inc $ 729 $ 214 $ -37 259
Editas Medicine Inc $ 723 $ 25 $ -195 -
Caribou Biosciences Inc $ 692 $ 35 $ -95 -
Hillevax Inc $ 680 - $ -108 -
Novavax inc $ 623 $ 1,050 $ -549 370
Adaptive Biotechnologies Corporation $ 618 $ 180 $ -196 645
Tscan Therapeutics Inc $ 612 $ 17 $ -88 -
Replimune Group Inc $ 590 - $ -210 -
Alector Inc $ 588 $ 96 $ -141 155
Mymetics Corporation $ 486 $ 1 $ -14 -
C4 Therapeutics Inc $ 484 $ 21 $ -132 -
Invivyd Inc $ 470 - $ -170 -
Humacyte Inc $ 469 - $ -89 -
Tenaya Therapeutics Inc $ 432 - $ -128 -
Iteos Therapeutics Inc $ 393 $ 128 $ -62 97
Voyager Therapeutics Inc $ 391 $ 158 $ 52 -
Freeline Therapeutics Holdings Plc $ 384 - $ -140 -
Surrozen Inc $ 380 - $ -35 -
Meiragtx Holdings Plc $ 367 $ 7 $ -132 -
Monte Rosa Therapeutics Inc $ 350 - $ -133 -
Poseida Therapeutics Inc $ 346 $ 52 $ -132 -
Aura Biosciences Inc $ 334 - $ -71 -
Scilex Holding Company $ 323 $ 71 $ -117 -
Kodiak Sciences Inc $ 322 - $ -271 -
Sophia Genetics Sa $ 321 $ 48 $ -87 -
Sutro Biopharma Inc $ 319 $ 49 $ -172 -
Gritstone Bio Inc $ 315 $ 10 $ -71 -
Taysha Gene Therapies Inc $ 308 $ 14 $ -215 -
Agenus Inc $ 303 $ 101 $ -283 -
Oyster Point Pharma Inc $ 300 $ 20 $ -235 -
Sab Biotherapeutics Inc $ 262 $ 4 $ -27 -
Eiger Biopharmaceuticals Inc $ 258 $ 15 $ -87 -
Coherus Biosciences inc $ 256 $ 211 $ -217 650
Ocugen Inc $ 254 - $ -76 -
Black Diamond Therapeutics Inc $ 249 - $ -84 -
Omega Therapeutics Inc $ 233 $ 3 $ -108 -
Compugen Ltd $ 229 $ 8 $ -34 -
Checkmate Pharmaceuticals Inc $ 227 - $ -63 -
Century Therapeutics inc $ 226 $ 2 $ -129 -
Compass Therapeutics Inc $ 224 - $ -41 -
Acumen Pharmaceuticals Inc $ 221 - $ -49 -
Inmune Bio Inc $ 218 $ 0 $ -27 -
Innate Pharma Sa $ 214 $ 65 $ -65 -
Solid Biosciences Inc $ 202 $ 15 $ -91 -
Adverum Biotechnologies Inc $ 202 $ 2 $ -126 -
Sangamo Therapeutics Inc $ 200 $ 201 $ -250 411
La Jolla Pharmaceutical Company $ 200 $ 46 $ 4 -
X4 Pharmaceuticals Inc $ 196 - $ -111 -
Vaxart Inc $ 193 $ 4 $ -89 -
Bluebird Bio Inc $ 191 $ 22 $ -91 -
Lineage Cell Therapeutics Inc $ 191 $ 9 $ -23 -
Genfit S a $ 182 $ 30 $ -27 194
Graphite Bio Inc $ 181 - $ -126 -
Apeiron Capital Investment Corp $ 180 - $ 7 -
Zura Bio Limited $ 173 - $ -61 -
Tourmaline Bio Inc $ 162 - $ -63 -
Xtant Medical Holdings Inc $ 160 $ 77 $ 3 -
Elevation Oncology inc $ 157 - $ -57 -
Athira Pharma Inc $ 153 - $ -121 -
Bioatla Inc $ 136 - $ -124 -
Vor Biopharma Inc $ 135 - $ -116 -
Vigil Neuroscience Inc $ 131 - $ -79 -
Protalix Biotherapeutics inc $ 131 $ 64 $ 11 -
Armata Pharmaceuticals Inc $ 127 $ 4 $ -60 -
Titan Pharmaceuticals Inc $ 127 $ 2 $ -6 -
Atyr Pharma Inc $ 116 $ 10 $ -43 -
Outlook Therapeutics Inc $ 115 - $ -51 -
Cardiol Therapeutics inc $ 108 - $ 0 -
Cel sci Corporation $ 99 - $ -31 -
Prokidney Corp $ 98 - $ -222 -
Jounce Therapeutics inc $ 97 $ 148 $ 0 125
Turnstone Biologics Corp $ 95 - $ 0 -
Miromatrix Medical inc $ 93 $ 1 $ -32 -
Passage Bio inc $ 85 - $ -112 -
Evaxion Biotech A $ 85 - $ -23 -
Atara Biotherapeutics Inc $ 85 $ 14 $ -290 -
Allovir Inc $ 84 - $ -169 -
Cardiff Oncology inc $ 80 $ 3 $ -23 -
Dbv Technologies S a $ 79 - $ -101 -
Genenta Science S p a $ 76 - $ -9 -
Champions Oncology Inc $ 75 $ 50 $ -10 -
Logicbio Therapeutics Inc $ 68 $ 11 $ -27 -
Cidara Therapeutics Inc $ 66 $ 41 $ -28 -
Ikena Oncology Inc $ 66 $ 14 $ -63 -
Phoenix Biotech Acquisition Corp $ 65 - $ -3 -
Surface Oncology Inc $ 65 $ 31 $ -93 -
Semper Paratus Acquisition Corporation $ 63 - $ 4 -
Tcr2 Therapeutics Inc $ 62 - $ -163 -
Cognition Therapeutics inc $ 60 - $ -23 -
Achilles Therapeutics Plc $ 58 - $ -71 -
Redwoods Acquisition Corp $ 58 - $ 5 -
Avrobio Inc $ 58 - $ -4 -
Elutia Inc $ 56 $ 42 $ -34 -
Renovacor Inc $ 56 - $ -4 -
Protara Therapeutics Inc $ 55 - $ -69 -
Candel Therapeutics Inc $ 50 $ 0 $ -32 -
Intensity Therapeutics Inc $ 49 - $ 0 -
Gamida Cell Ltd $ 47 - $ 79 -
Greenlight Biosciences Holdings Pbc $ 45 $ 10 $ -157 -
Aligos Therapeutics Inc $ 41 $ 16 $ -82 -
Dyadic International Inc $ 41 - $ 2,482 84
Estrella Immunopharma Inc $ 37 - $ -4 -
In8bio Inc $ 35 - $ -30 -
Mink Therapeutics Inc $ 32 - $ -25 -
Pluri Inc $ 32 $ 0 $ -24 -
Axcella Health Inc $ 30 - $ -48 -
Entera Bio Ltd $ 29 - $ 5 -
Lexeo Therapeutics Inc $ 27 - $ 0 -
Cyclo Therapeutics Inc $ 27 $ 1 $ -19 -
Applied Genetic Technologies Corporation $ 26 $ 42 $ -70 -
Senti Biosciences Inc $ 20 $ 4 $ -82 -
Aim Immunotech Inc $ 20 - $ -22 -
Cargo Therapeutics Inc $ 18 - $ 0 -
Erytech Pharma S a $ 18 - $ -60 -
Pharmacyte Biotech Inc $ 18 - $ -2 -
Acorda Therapeutics Inc $ 17 $ 111 $ -16 327
Brainstorm Cell Therapeutics inc $ 16 - $ -17 -
Zivo Bioscience Inc $ 15 - $ -9 2
Sorrento Therapeutics Inc $ 15 - $ 0 -
Nkgen Biotech Inc $ 13 - $ -38 -
Aptose Biosciences Inc $ 12 - $ -49 -
Calidi Biotherapeutics Inc $ 12 - $ -11 -
Inhibikase Therapeutics Inc $ 12 $ 0 $ -19 -
Green Planet Bioengineering Co Ltd $ 12 - $ 0 -
Biocardia Inc $ 11 $ 1 $ -13 -
Organovo Holdings Inc $ 9 $ 0 $ -19 -
Old Ayala Inc $ 8 $ 1 $ -38 -
Allena Pharmaceuticals Inc. $ 8 - $ -43 -
Tracon Pharmaceuticals Inc $ 7 $ 11 $ -11 -
Enzon Pharmaceuticals inc $ 6 $ 2 $ 1 -
Creative Medical Technology Holdings Inc $ 6 $ 0 $ -10 -
Fresh Tracks Therapeutics Inc $ 5 $ 10 $ -9 -
Rubius Therapeutics Inc $ 5 - $ -180 -
Nanostring Technologies Inc $ 5 $ 162 $ -166 721
Finch Therapeutics Group Inc $ 4 $ 1 $ -100 -
Avalon Globocare Corp $ 4 $ 1 $ -9 -
Kiromic Biopharma Inc $ 4 - $ -23 -
Qrons Inc $ 3 - $ -2 -
Palisade Bio Inc $ 3 - $ -13 -
Aceragen Inc $ 3 - $ -41 -
Peak Bio Inc $ 2 - $ -26 -
Eloxx Pharmaceuticals Inc $ 2 - $ -32 -
Clarus Therapeutics Holdings Inc. $ 2 $ 8 $ -23 -
Windtree Therapeutics Inc $ 2 $ 1 $ -25 -
Codiak Biosciences Inc $ 1 $ 34 $ -17 -
Polarityte Inc $ 1 $ 3 $ -8 -
Sqz Biotechnologies Company $ 1 - $ 0 -
Ladrx Corporation $ 1 - $ 1 -
Tc Biopharm holdings Plc $ 1 $ 4 $ -1 -
Organicell Regenerative Medicine Inc $ 0 $ 5 $ -7 -
Cannabis Global Inc. $ 0 $ 4 $ -4 -
Genocea Biosciences Inc $ 0 $ 21 $ -37 -
Point Of Care Nano technology Inc $ 0 - $ 0 -
Replicel Life Sciences Inc - - $ -1 -
10x Capital Venture Acquisition Corp Iii - - $ -1 -
Agentix Corp - - $ -1 2
Biontech Se - $ 540 $ 11,528 1,700
Spk Acquisition Corp - - $ -1 -
Coeptis Therapeutics Holdings Inc - - $ -57 -
Mosaic Immunoengineering Inc - - $ -1 -
Biomx Inc - - $ 27 -
Fennec Pharmaceuticals Inc - $ 13 $ -20 -
Anavex Life Sciences Corp - $ 3 $ -43 -
Forma Therapeutics Holdings Inc. - - $ -190 -
Biondvax Pharmaceuticals Ltd - - $ -1 -
Biotechnology & Pharmaceuticals Industry $ 557,918 $ 87,060 $ 3,927 70,697
  Recent News from Biotechnology & Pharmaceuticals Industry
Product Service News

BioAegis Therapeutics Paves Path to ARDS Paradigm Shift with Revolutionary Gelsolin Study

BioAegis Therapeutics Unveils Revolutionary Study of Gelsolin as an Immune Regulator for Acute Respiratory Distress Syndrome (ARDS)In a groundbreaking announcement, BioAegis Therapeutics has revealed plans for a global Phase 2 clinical study that explores the potential of gelsolin, an inflammation regulator protein, as a treatment for the life-threatening...

Springworks Therapeutics Inc

The company reported Revenue of $5.447 million, in the fiscal interval ending December 31 2023

Springworks Therapeutics Inc is a biopharmaceutical company based in Stamford, Connecticut, specializing in the development of innovative treatments for severe rare diseases and various forms of cancer. The company recently announced its financial results for the most recent fiscal period, reporting a revenue of $5.447 million. However, the company also d...

Product Service News

Scilex Holding Company Amplifies Non-Opioid Pain Management Advancements at AAPM Annual Meeting

Abstract:Scilex Holding Company (Scilex), a revenue-generating pharmaceutical company specializing in non-opioid pain management products, has announced the acceptance of an abstract for poster and oral presentation at the 2024 Annual Meeting of the American Academy of Pain Medicine (AAPM). The meeting is scheduled for March 7-10, 2024, in Scottsdale, Ari...

Shares

Denali Therapeutics Inc. Announces $500 Million PIPE Financing to Support Research and Development Activities


Denali Therapeutics Inc., a leading biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases and lysosomal storage diseases, has recently announced a significant private investment in public equity (PIPE) financing. The company has entered into a securities purchase agreement with accredited investors to is...

Vir Biotechnology Inc

Vir Biotechnology Inc Faces Larger Loss in Latest Fiscal Period, But Shows Signs of Recovery

Despite the recent disappointing fiscal period declared by Vir Biotechnology Inc, there are signs of potential growth and recovery for the company. While revenue saw a significant decline of -66.025%, it is important to note that revenue doubled sequentially from the previous reporting period, showing signs of improvement. Additionally, the company report...

Krystal Biotech Inc

Krystal Biotech Inc's Fourth Quarter Results: Revenue Reaches $42.143 Million 2.

The recent financial results of Krystal Biotech Inc, a biotechnology and pharmaceutical company, have showcased significant improvements and positive trends. In the fourth quarter of 2023, the company achieved revenue of $42.143 million, indicating promising growth in its operations.
One of the most notable achievements is the company's bottom-line im...

Announcement

AlloVir, Inc. Faces Securities Lawsuit: A Call for Transparency and Accountability in Biopharmaceutical Investing.

AlloVir, Inc. Faces Class Action Lawsuit for Securities Law Violations - Investors Advised to Seek Legal Assistance from Levi and KorsinskyThe pharmaceutical industry has always been a lucrative market, attracting investors from all corners of the world. However, with the potential for high returns also comes the risk of securities law violations, as rece...

Product Service News

Unleashing the Potential: HDAC6 Inhibition for Heart Failure with Preserved Ejection Fraction

In recent years, heart failure with preserved ejection fraction (HFpEF) has emerged as a significant health challenge, with limited treatment options available. However, a recent publication in Nature Communications by Tenaya Therapeutics has shed light on a potential breakthrough. Their preclinical data presents promising findings on the use of HDAC6 inh...

Clinical Study

Breakthrough Gene Therapy Candidate Shows Promise for Friedreich's Ataxia Treatment

Friedreich's ataxia (FA) is a debilitating genetic neurodegenerative disorder that affects approximately 1 in 50,000 individuals worldwide. Characterized by progressive loss of coordination, muscle weakness, and impaired speech, FA significantly reduces the quality of life for affected individuals. However, a ray of hope shines through recent advancements...

Clinical Study

Catalyzing a Paradigm Shift: TScan Therapeutics' TSC-100 and TSC-101 Propelling Patients to Relapse-Free Remission and Complete Donor Chimerism

is pleased to report on the highly promising and groundbreaking Phase 1 clinical results presented by TScan Therapeutics at the prestigious 2024 Tandem Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR). These results showcase the company's innovativ...







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com